Start Time: 16:35
End Time: 17:01
OncoGenex Pharmaceuticals, Inc. (OGXI)
Q4 2013 Earnings Conference Call
March 11, 2014 4:30 PM ET
Susan W. Specht – Director-Investor Relations
Scott Cormack – President and...
TORONTO, ON -- (Marketwired) -- 03/11/14 -- Easton Pharmaceuticals Inc. (OTC: EAPH), a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare...
San Diego biotech Lumena Pharmaceuticals has nailed down a $45 million B round with plans to move forward with treatments for two liver diseases, one a painful orphan condition and the other a fast-spreading cause célèbre in the biotech world.
CHARLESTON, SC -- (Marketwired) -- 03/10/14 -- The recent commercial coverage of a new oral contraceptive signals a possible shift in the market toward low-cost pharmaceuticals. Afaxys Pharmaceuticals (
www.afaxys.com/pharma) received FDA...
Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) today confirmed that Takeda
Pharmaceutical Company Limited announced that it has submitted a New
Drug Application (NDA) to the Japanese Ministry of Health, Labour and
By Don Dion:
Aquinox Pharmaceuticals Inc (AQXP), a clinical-stage pharmaceutical firm, developing inflammation and cancer treatments, plans to raise $41 million in its upcoming IPO.
The Vancouver, Canada-based firm will offer 3.7 million shares...